Oxford University and UK clinical artificial intelligence (AI) company Sensyne Health will partner on a project to find new drug targets for people with hard-to-treat asthma.
Researchers at Cambridge University in the UK are trialling an artificial intelligence system that they think could spot the signs of dementia after a single brain scan.
The most complete database of protein structures ever assembled, developed with the help of Google's artificial intelligence unit DeepMind, has been made freely available to researchers aro
Think of the R&D dollars that could be saved if artificial intelligence (AI) modelling could tell you at an early stage whether a drug was likely to succeed in clinical trials, and ulti
Scientists in the US have developed an artificial intelligence-powered 'clock' that can estimate a person's chance of developing an illness or dying based on the pattern of cytokines in the
Merck & Co (MSD outside the United States) celebrated the tenth anniversary of the first Keytruda approval at ASCO this year, but the company isn’t resting on its laurels.